Open AccessErratum
Author(s) -
Gualtiero Palareti,
Benilde Cosmi
Publication year - 2004
Publication title -
current opinion in hematology/current opinion in hematology, with evaluated medline
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.295
H-Index - 97
eISSN - 1080-8213
pISSN - 1065-6251
DOI - 10.1097/01.moh.0000132310.18883.c0
Subject(s) - medicine , thrombophilia , antithrombin , risk factor , persistence (discontinuity) , thrombosis , residual risk , factor v leiden , venous thromboembolism , venous thrombosis , intensive care medicine , heparin , geotechnical engineering , engineering
Although several clinical studies have investigated the effects of different treatment periods in subjects after a VTE event, the optimal duration of oral anticoagulation is still uncertain. Our review focused on studies that evaluated different risk factors that might be useful to stratify patients into categories at different risk for recurrence.